Clinical Trials · NCT05221229
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- University Hospital Birmingham
- Enrollment
- 29
- Start date
- Apr 2022
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Adherence to Liraglutide by AF patients before and after first-time ablation [Time Frame- 13 weeks before and 52 weeks after ablation]